For the first time in U.S. history, the federal government is registering the medical marijuana dispensaries patients fought to build. On Friday, October 30, the Department of Justice announced the DEA had issued its first federal registrations to more than 900 dispensaries — while 6,083 more businesses sat still waiting on the DEA's own list.
The First Federal Registrations
The initial registrations cover more than 900 dispensaries across seven states: Alabama, Florida, Mississippi, South Dakota, Texas, Virginia, and West Virginia.
Federal officials did not name any business and did not give a count for any state. Each dispensary had to satisfy applicable federal requirements and pass the DEA's pre-registration investigation before it was registered.
"The American people deserve access to the best medical treatments in the world," Attorney General Todd Blanche said in the announcement. "The regulated distribution of medical marijuana by the applicants that have been granted registration by the Drug Enforcement Administration will help ensure broader access to chronic pain treatment and the safety of the American people."
Blanche added that the Department of Justice "will continue prosecuting illegal marijuana trafficking and related criminal activity in accordance with federal law."
A state license alone is not enough. Registered dispensaries will now be subject to federal requirements on security, recordkeeping, inventory controls, and other safeguards for handling controlled substances.
Steph Sherer, founder and executive director of Americans for Safe Access, called it "a tremendous victory for patient access."
"For the first time, the federal government is recognizing and registering the medical cannabis dispensaries that patients fought to establish," Sherer said — a milestone arriving as the country approaches the 30th anniversary of California's Proposition 215, the nation's first statewide medical cannabis law.
Update — November 2, 2026: A Registrant Names Itself
The Justice Department named no businesses in its October 30 announcement. On November 2, one named itself.
Trulieve Cannabis Corp. announced that it has received DEA registrations for its state-licensed medical marijuana dispensaries, as part of the initial registrations the DEA began issuing on Friday. The company said it applied for DEA registration in April, following the rescheduling of state-licensed medical marijuana to Schedule III.
Trulieve did not disclose how many registrations it received, or in which states they were issued. Its release lists established medical marijuana operations in Florida, Georgia, Pennsylvania, and West Virginia — Florida and West Virginia are among the seven states named in the first registration round above. Whether the registrations cover all four of its states, the company did not say.
"Today marks another historic milestone for patients, physicians, and Trulieve, made possible by the bold action taken by the Trump Administration on common sense cannabis reform," said Trulieve Chief Executive Officer Kim Rivers. "Federal reclassification of state licensed medical marijuana opens the door for clinical research while creating a level playing field for responsible operators like Trulieve. We appreciate the DEA's work to advance this historic change and its continued engagement with state-licensed medical cannabis operators as the new federal framework is implemented."
Update — November 3, 2026: Vireo Growth Names Itself as Well
Vireo Growth Inc. announced on November 2, 2026, that it has received DEA registrations for all 41 of its state-licensed medical cannabis dispensaries in Florida — the second company, after Trulieve, to publicly confirm registrations under the program covered in this story. Vireo said its registrations are among the initial federal registrations issued to qualifying state-licensed medical marijuana dispensaries under the new Schedule III framework established by the DEA's April 2026 final rule. "Florida is one of our key markets, and we are pleased to have received these registrations," said Vireo Chief Executive Officer John Mazarakis. "We appreciate the DEA's efforts in advancing this process and welcome continued progress toward a federal regulatory framework that recognizes responsible, state-licensed cannabis operators and supports a more stable and sustainable industry." Vireo (CSE: VREO; OTCQX: VREOF) operates in 10 states with approximately 180 dispensaries nationwide.
How We Got Here
These registrations are the first phase of implementing Attorney General Order No. 6754-2026, signed April 23 and published in the Federal Register on April 28, 2026. The road there started on December 18, 2025, when President Donald Trump signed an executive order addressing medical marijuana and cannabidiol research.
Under 21 U.S.C. § 811(d), that order moved two categories of marijuana from Schedule I to Schedule III of the Controlled Substances Act: FDA-approved marijuana drug products, and marijuana covered by a qualifying state medical marijuana license. It also set up an expedited DEA registration track for state medical licensees.
The DEA started with dispensaries that applied inside the order's initial 60-day window, which closed June 26. To qualify, an applicant must operate under a state medical marijuana framework consistent with federal law and the United States' international treaty obligations.
6,083 Businesses Still Waiting
The DEA is publishing a daily list of "Timely Applicants" — businesses that filed a complete application, with the fee paid, inside that 60-day window and whose applications remain pending.
That list started at 6,983 entries when it was posted October 30. The November 1 version lists 6,083 businesses: 3,298 dispensaries, 2,075 manufacturers, and 710 distributors. Oklahoma has far more entries than any other state, with 2,442.
Dispensary entries fell by 899 between the two files, and every one of those removals came from the seven states named in the first registrations. The file does not say why an entry was removed, does not name companies, and shows only a state, a business type, and a DEA document control number for each applicant.
More registrations are coming in phases, the Justice Department said. Applications from manufacturers and distributors — the businesses that supply dispensaries — are still under review, and those require additional review, including facility inspections, production controls, and quota determinations. The DEA only opened its application process for manufacturers, distributors, and laboratories in early October — which raises an immediate question: dispensaries are being registered before many of the cultivation and distribution businesses that supply them.
The November 29 Supply-Chain Deadline
Registration comes with a deadline that could reshape shelves before the end of the month.
In guidance issued alongside the registrations, the DEA said registered businesses and timely applicants may lawfully do Schedule III medical marijuana business only with other registrants or timely applicants. Timely Applicants may keep operating under their state licenses while their applications are pending — an exception to the ordinary rule that a controlled-substance business must be registered before it operates — and may keep selling inventory acquired before the guidance was issued.
They are expected to verify their trading partners — by reviewing a partner's application submission confirmation and document control number, checking it through the DEA's Diversion Control website, and for a partner already registered, by getting a copy of its DEA certificate — confirm the partner still holds an active state license, keep records of those checks, and establish compliant supply chains no later than November 29, 2026.
Doing Schedule III business with an entity that did not apply on time, until that entity becomes a registrant, could be grounds to deny a pending application or revoke a registration.
There is one narrow exception: the DEA does not plan to penalize registrants and timely applicants for sending small — "de minimis" — quantities of medical cannabis to a state-licensed testing laboratory in the same state that does not yet hold DEA registration, provided records of each transfer are kept.
The DEA letter itself states that the guidance does not have the force and effect of law — it states the agency's enforcement intentions, it is not a binding statute or regulation.
The Catch: Dual Licenses
Six of the seven states in the first round run medical-only programs. Virginia is the exception — it has legalized adult-use, but has not yet started licensed adult-use retail sales. The first round does not answer what happens in states where medical and recreational cannabis share one license.
Minnesota gave an early answer. The DEA sent Minneapolis business In-Dispensary an order to show cause refusing registration, saying Minnesota's "dual-purpose marijuana license, permitting both medical and non-medical dispensing falls outside" the federal definition of a state medical license.
"For DEA to sanction or bestow the imprimatur of legitimacy upon such conduct by granting a registration would be inconsistent with the [Controlled Substances Act] as well as United States' treaty obligations," the order, signed by Diversion Control Assistant Administrator Cheri Oz, said. The order also cited Minnesota's regime as lacking "robust protections" against diversion.
In-Dispensary has 30 days to request a hearing or submit a corrective action plan. Minnesota's Office of Cannabis Management said the order does not impact the state law authorizing Minnesota's medical and adult-use programs.
What This Does Not Do
The Attorney General's order applies only to defined, qualifying medical marijuana activities. It does not authorize recreational marijuana. Marijuana not covered by the order remains subject to Schedule I controls.
The broader proposal to reschedule marijuana itself is a separate administrative proceeding — it is not decided by these registrations.
And these registrations do not create a national medical program. Patients still follow their own state's program, cards, and certifications, and federal registration does not by itself guarantee insurance coverage, interstate transport, or workplace, housing, or hospital protections.
The Reaction: "Built to Fail"
Not everyone in the comments read the announcement as a victory.
"😂😂😂😂😂😂 it's like it was built to fail," wrote poetryofplants — a comment that drew 56 likes and 7 replies.
smokyditch read the registration as the government taking over an industry it spent decades fighting:
"In other words... We fked this up for 50 years. We ste completelty lost: Thank you all for making an industry out of where no one hurt.... 'WE WILL TAKE IT FROM HERE'.... Quote from #NOTSODOG. #FreetheSeed"
The same skepticism ran through the comments on Cannabis Wise Guys' November 1 reel on the registrations, which had drawn 992 likes and 62 comments when it was captured. Commenters called the framework "Prohibition 2.0," worried it would "squash the little guy," promoted a forthcoming documentary titled "How to Monopolize the Marijuana Industry," and predicted some operators would stay in, or return to, the legacy market instead. One commenter, bo_lo, put that last response in five words: "Support your local Black Market." Those are commenters' allegations and fears, not findings about the government's intentions.
One commenter identifying himself as a West Virginia operator claimed his facility had been inspected the previous week and alleged a fee of $113 per kilogram at harvest, describing a process in which businesses effectively sell product into the system and buy it back. That claim is unverified — nothing in the DOJ announcement or DEA guidance establishes a $113-per-kilogram fee as an official DEA charge or a general requirement of the registration program. It is included here only as an example of the cost uncertainty operators are voicing.
Not every comment was negative. A smaller group hoped federal registration could eventually bring clearer rules, stronger patient protections, interstate medical access, workplace protections, and easier banking. The registration itself guarantees none of those — each depends on further legal, regulatory, and institutional decisions.
That split — patient advocates calling it a historic win, growers and longtime operators calling it a takeover built to fail — is the tension the next phases will have to answer.
What Comes Next
The DEA will keep processing dispensary applications through its phased process, and will keep updating the Timely Applicant list daily as businesses are registered, withdraw, or stop being considered timely.
For patients, advocates say the next fight is implementation — especially in dual-license states. For operators still on that list of 6,083, the immediate fight is the calendar: a federal registration if it comes, and a compliant supply chain by November 29 either way.
Sources
U.S. Department of Justice, Office of Public Affairs. "Justice Department Announces Issuance of Federal Registrations for Medical Marijuana Dispensaries." Press release, October 30, 2026. — The primary announcement: more than 900 dispensaries in seven states; first phase of the April 23 order under 21 U.S.C. § 811(d); Blanche quote; federal requirements; manufacturers/distributors additional review; recreational not authorized.
U.S. Drug Enforcement Administration, Diversion Control Division. "Medical Marijuana Information." Accessed November 2, 2026. — DEA Timely Applicant list page, updated daily.
Department of Justice / DEA. AG Order No. 6754-2026, 91 Federal Register 22714, April 28, 2026. — Schedule III move for FDA-approved products and state-licensed medical marijuana.
CannabisNews.org. "DEA List Shows 6,083 Medical Marijuana Businesses Still Awaiting Federal Registration After First Dispensary Approvals." November 1, 2026. — Comparison of Oct 30 (6,983) and Nov 1 (6,083) DEA files, with breakdown by type and state.
Roberts, Chris. "First DEA Medical Marijuana Registrations Issued." MJBizDaily, October 30, 2026.
Marijuana Moment. "DEA Officially Grants Federal Registration and Protections to More Than 900 Medical Marijuana Dispensaries." October 30, 2026; "Nearly 7,000 Marijuana Businesses Have Applied…," October 30, 2026; "DEA Refuses to Approve Marijuana Businesses in States That Allow Dual Medical and Recreational Licensing," October 2026; Sherer, Steph, Op-Ed, November 2, 2026.
Cannabis Business Times. "DEA Rules for Schedule III Medical Cannabis Registrants Pose Major Disruptions to State Programs." October 30, 2026. — Reporting on the DEA's permissible-activities guidance: supply-chain realignment by November 29, partner verification, denial/revocation risk, de minimis lab exception.
Beard Bros Pharms. "DEA Opens Schedule III Portal for Cannabis Manufacturers." October 2026; "DEA Medical Marijuana Registration Portal Officially Opens Today." 2026. — Background on the registration pathway: dispensary portal opened April 29, manufacturers/distributors/labs added through Form 225, medical and FDA-approved products only.
U.S. Drug Enforcement Administration. "DEA Medical Marijuana Timely Applicant Information." DEA Diversion Control Division, October 30, 2026. — The DEA's timely-applicant guidance letter: who counts as a Timely Applicant, trading only with registrants/timely applicants, verification steps, November 29 date, and the statement that the guidance does not have the force and effect of law.
Cannabis Wise Guys (@cannabiswiseguys). Instagram reel on federal medical marijuana registrations and public reaction, November 1, 2026. — Source for the wider comment reaction: "Prohibition 2.0," the monopoly documentary, legacy-market predictions, the unverified West Virginia $113-per-kilogram claim, and the hopeful banking/patient comments.
Instagram comments on the nuggnotes DEA post, screenshots supplied by Angel, November 2, 2026. — poetryofplants: "it's like it was built to fail"; smokyditch, quoting #NOTSODOG: "WE WILL TAKE IT FROM HERE" / #FreetheSeed. Transcribed exactly as shown in the screenshots.
"DEA Issues First Federal Registrations to MMJ Dispensaries, Sets November 29 Supply Chain Deadline." MMJ Daily, November 2, 2026. — Corroborating coverage of the registrations, Timely Applicant definition, and November 29 deadline.
"DEA Issues First Federal Registrations to 900-Plus Medical Marijuana Dispensaries in Seven States." Cannabis News, October 31, 2026. — Corroborating coverage of the October 30 announcement and the seven states.
Trulieve Cannabis Corp. "Trulieve Receives DEA Registrations for State-Licensed Medical Marijuana Operations." PR Newswire, November 2, 2026. — The first registrant to publicly identify itself: the company says it received DEA registrations for its state-licensed medical marijuana dispensaries as part of the initial issuance, and that it applied in April following the Schedule III rescheduling; CEO Kim Rivers quote; established medical marijuana operations listed as Florida, Georgia, Pennsylvania, and West Virginia. The release discloses no registration count and no per-state breakdown. prnewswire.com/news-releases/trulieve-receives-dea-registrations-for-state-licensed-medical-marijuana-operations-302926512.html
Vireo Growth Inc. — "Vireo Growth Inc. Receives Federal DEA Registrations for Florida Medical Cannabis Dispensaries," GlobeNewswire, November 2, 2026.
0 comments